Abstract
In the past, contradictory results have been reported concerning the specificity of neuronal or glial cell markers. However, we have investigated this aspect in a large group of more than 550 brain tumors (among them 60 medulloblastomas). These contradictions can easily be explained by considering two basic facts. First, every neoplastic cell population, especially in embryonic tumors, diffusely infiltrates the brain tissue: non-neoplastic cells, intermingled with tumor cells, can therefore give rise to immunohistochemical and histogenetic misinterpretations. Second, different cell markers can be expressed by one and the same cell (e.g., GFAP, NSE, vimentin), making nosological interpretation of the tumor difficult, impossible, or at best rather subjective. Clear-cut marker positivity is mostly found in the differentiated tumors for which the nosological classification is already clear by the usual histological methods. Only synaptophysin seems to be a reliable marker for neurogenic cells. In embryonic brain tumors (so-called PNET), no correlations between the presence of a given cell marker and the biological behavior of the tumor have so far been detected.
Similar content being viewed by others
References
Budka H (1986) Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Acta Neuropathol 72:43–54
Ghobrial M, Ross ER (1986) Immunocytochemistry of neuronspecific enolase: a reevaluation. (Progress in neuropathology, vol 6). Raven Press, New York, pp 199–221
Gullotta F, Kuchelmeister K (1986) GFAP bei Hirntumoren. Verh Dtsch Ges Pathol 70: 380–381
Gullotta F, Schindler F, Schmutzler R, Weeks-Seifert A (1985) GFAP in brain tumor diagnosis: possibilities and limitations. Pathol Res Pract 180:54–60
Kleihues P, Kiessling M, Janzer RC (1987) Morphological markers in neuro-oncology. Curr Top Pathol 77:307–329
Nakazato Y, Ishida Y, Takahashi K, Suzuki K (1985) Immunohistochemical distribution of S-100 protein and glial fibrillary acidic protein in normal and neoplastic salivary glands. Virchows Arch [A] 405:299–310
Paulus W, Peiffer J (1988) Does the pleomorphic xanthoastrocytoma exist? Problems in the application of immunological techniques to the classification of brain tumors. Acta Neuropathol 76:245–252
Pinto A, Lester HG, Hayes FA, Schell MJ, Parham DM (1989) Immunohistochemical expression of neuron-specific enolase and leu 7 in Ewing's sarcoma of bone. Cancer 67:1266–1273
Roessner A, Garcia H, Vollmer E, Grundmann E (1988) Differential diagnosis of Ewing's sarcoma: an immunohistochemical analysis. J Cancer Res Clin Oncol, Suppl to Vol 114
Rubinstein LJ (1986) Immunohistochemical signposts — not markers — in neural tumour differentiation. Neuropathol Appl Neurobiol 12:523–537
Schindler E, Gullotta F (1983) Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children. Virchows Arch [A] 398:263–275
Schwechheimer K (1986) Nervale Tumormarker. Verh Dtsch Ges Pathol 70:82–103
Schwechheimer K, Wiedenmann B, Franke WW (1987) Synaptophysin: a reliable marker for medulloblastomas. Virchows Arch [A] 411:53–59
Sternberger LA (1986) Immunocytochemistry, 3rd edn. Wiley, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gullotta, F. Immunohistochemistry in childhood brain tumors: what are the facts?. Child's Nerv Syst 6, 118–122 (1990). https://doi.org/10.1007/BF00308484
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00308484